Shares of Theratechnologies Inc. (TSE:TH - Get Free Report) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$1.78 and traded as high as C$2.16. Theratechnologies shares last traded at C$2.15, with a volume of 28,012 shares trading hands.
Theratechnologies Price Performance
The stock has a market capitalization of C$98.86 million, a P/E ratio of -11.94, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73. The company has a debt-to-equity ratio of 562.07, a current ratio of 1.10 and a quick ratio of 0.64. The company's 50-day simple moving average is C$1.78 and its 200-day simple moving average is C$1.81.
Theratechnologies (TSE:TH - Get Free Report) last announced its quarterly earnings results on Thursday, October 10th. The company reported C$0.09 earnings per share for the quarter. Theratechnologies had a negative return on equity of 1,116.86% and a negative net margin of 8.47%. The firm had revenue of C$30.96 million for the quarter. As a group, sell-side analysts expect that Theratechnologies Inc. will post 0.0298643 EPS for the current fiscal year.
Theratechnologies Company Profile
(
Get Free Report)
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Read More
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
